Enhancing the efficacy of immunotherapy in lung cancer

Enhancing the efficacy of immunotherapy in lung cancer

Biopharma Enhancing the efficacy of immunotherapy in non-small cell lung cancer using an RGD-mimetic   Queen Mary scientists led by Prof Kairbaan Hodivala-Dilke have invented a new methodology for treating lung cancer – the leading cause of cancer deaths...
Reversing tumour resistance to kinase inhibitors

Reversing tumour resistance to kinase inhibitors

Biopharma Reversing tumour resistance to kinase inhibitors   Drug resistance is behind most relapses in cancer patients. This is partly why anti-cancer drugs targeting oncogenic kinase signalling have failed to live up to expectations. Kinase inhibitors are only...
A Rapid PCR Test for Early Cancer Diagnosis

A Rapid PCR Test for Early Cancer Diagnosis

Biopharma A Rapid PCR Test for Early Cancer Diagnosis   A novel qPCR-based diagnostic test for detecting oral cancer risk and predicting patient prognosis. qMIDSv2 is low cost, rapid, and minimally invasive. It requires only 1mm3 of biopsy material and is applicable...
Developing inhibitors to target activated fibroblasts

Developing inhibitors to target activated fibroblasts

Biopharma Developing inhibitors to target activated fibroblasts   A drug discovery program has led to promising and selective pharmacological inhibitors to target activated fibroblasts in cancer and other fibrotic diseases. Researchers have identified a target that...
A new method for detecting circulating tumour cells

A new method for detecting circulating tumour cells

Biopharma Megakaryocytes and circulating tumour cells as a cancer prognostic marker   Prostate cancer is the most common cancer in Western men and the second most frequent cause of cancer-related death. Most prostate cancer deaths are caused by metastases, which are...